Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Sep 14;14:5683. doi: 10.1038/s41467-023-41473-6

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 6 — a Representative IHC of PDGFRα in Normal-Healthy, NATs, and/or tumors of women of AA and EA. b Enlarged view of PDGFRα expression in Normal-Healthy and tumor. c Differences in PDGFRα expression (positivity and H-score) between Normal-Healthy tissues of women of AA and EA analyzed using two-sided Wilcoxon test (positivity *p = 0.000000251 and H-score *p = 0.000014339). d Differences in PDGFRα expression (positivity and H-score) between Normal-Healthy and NATs of women of AA and EA analyzed using two-sided Wilcoxon test. e Differences in PDGFRα expression (positivity and H-score) between NATs and tumors of women of AA and EA. The data were analyzed using two-sided Wilcoxon test. (Normal-Healthy-AA (n = 35), EA (n = 154),; NAT -AA (n = 24) and EA (n = 42); Tumor -AA (n = 29) and EA (n = 52).) All the data points are shown as mean ± SD. Source data are provided as a Source Data file.